Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Catherine Vasilakis-Scaramozza"'
Autor:
Catherine Vasilakis‐Scaramozza, Katrina Wilcox Hagberg, Rebecca Persson, Eleanor Yelland, Tim Williams, Puja Myles, Susan S. Jick
Publikováno v:
Pharmacoepidemiology and Drug Safety. 32:73-77
While several studies have assessed quality and completeness of recording acute medical events in Clinical Practice Research Datalink (CPRD) Aurum, evaluation of additional chronic conditions is warranted.We selected patients with a first diagnosis o
Autor:
Todd Sponholtz, Rebecca Persson, Puja R. Myles, Tim Williams, Susan S. Jick, Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, Dipak Kotecha
Publikováno v:
Clinical Epidemiology
Rebecca Persson,1 Todd Sponholtz,1 Catherine Vasilakis-Scaramozza,1 Katrina Wilcox Hagberg,1 Tim Williams,2 Dipak Kotecha,3 Puja Myles,2 Susan S Jick1,4 1Epidemiology, Boston Collaborative Drug Surveillance Program, Lexington, MA, USA; 2Clinical Prac
Autor:
Yiran Qian, Rebecca Persson, Susan S. Jick, Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza
Publikováno v:
Journal of the American Academy of Dermatology. 83:271-274
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 34:1755-1763
Background Anxiety and depression are common among psoriasis and psoriatic arthritis (PsA) patients, but rates may differ by treatment. Objective To quantify the risk of incident treated anxiety, depression and mixed anxiety + depression in users of
Autor:
Rebecca Persson, Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, Eleanor Yelland, Tim Williams, Puja Myles, Susan S Jick
Publikováno v:
Clinical epidemiology. 14
Rebecca Persson,1 Katrina Wilcox Hagberg,1 Catherine Vasilakis-Scaramozza,1 Eleanor Yelland,2 Tim Williams,2 Puja Myles,2 Susan S Jick1,3 1Boston Collaborative Drug Surveillance Program, Lexington, MA, USA; 2Clinical Practice Research Datalink, Medic
Autor:
Katrina Wilcox Hagberg, Todd Sponholtz, Rebecca Persson, Susan S. Jick, Catherine Vasilakis-Scaramozza, Tim Williams, Puja R. Myles
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 29(11)
Purpose The Clinical Practice Research Datalink (CPRD) now provides a new medical record database, CPRD Aurum. This is the second of several studies being undertaken to assess the quality of CPRD Aurum data for research. Methods We included patients
Autor:
Yiran Qian, Rebecca Persson, Katrina Wilcox Hagberg, Catherine Vasilakis-Scaramozza, Susan S. Jick
Publikováno v:
Rheumatology (Oxford, England). 60(4)
Objectives People with PsA are at increased risk of cardiovascular disease. The objective of this study was to quantify the risk of myocardial infarction (MI), stroke and revascularizations in people with apremilast-treated PsA compared with patients
Autor:
Anders Lindholm, Susan S. Jick, Rebecca Persson, Michael Peng, Catherine Vasilakis-Scaramozza, Katrina Wilcox Hagberg, Steve Niemcryk, Maria Paris
Publikováno v:
Clinical Epidemiology
Katrina Wilcox Hagberg,1 Rebecca Persson,1 Catherine Vasilakis-Scaramozza,1 Steve Niemcryk,2 Michael Peng,2 Maria Paris,2 Anders Lindholm,2 Susan Jick1,3 1Boston Collaborative Drug Surveillance Program, Lexington, MA 02421, USA; 2Celgene Corporation,
Autor:
Catherine Vasilakis-Scaramozza, Susan S. Jick, Rebecca Persson, Katrina Wilcox Hagberg, Tim Williams, Elizabeth Crellin, Puja R. Myles
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 29(9)
Purpose The Clinical Practice Research Datalink (CPRD) now provides a new medical record database, CPRD Aurum. This is the first of several studies being undertaken to assess the quality and completeness of CPRD Aurum data for research endeavors. Met
Autor:
Rebecca Persson, Ellen Qian, Catherine Vasilakis-Scaramozza, Michael Peng, Steve Niemcryk, Maria Paris, Susan S. Jick, Katrina Wilcox Hagberg, Anders Lindholm
Publikováno v:
Abstracts accepted for Publication.
Background: Patients with psoriatic arthritis (PsA) are at increased risk for cardiovascular events, but different treatment options may not have the same rates of cardiovascular events.1,2 Objectives: To compare rates of myocardial infarction (MI),